Feedback / Questions
ANPD001 - Aspen Neurosci
https://www.prnewswire.com/news-releases/aspen-neuroscience-initiates-cohort-3-in-aspiro-phase-12a-trial-highlighting-commercial-formulation-of-anpd001-and-its-transformative-potential-for-parkinsons-disease-302566431.html
Sep 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next